Seroconversion of hepatitis B during chemotherapy for malignant lymphoma

Yona Kitay-Cohen, Avishay Elis, Arie Lalkin, Michael Lishner

Research output: Contribution to journalArticlepeer-review

Abstract

We report a patient with chronic hepatitis B infection who developed lymphoma and was treated with concomitant cytotoxic and antiviral therapy. In contrast to the expected life threatening fulminant hepatitis that is often reported in this clinical setting, in our patient normalization of liver function tests with temporary loss of viral replication markers were seen. The implications of this rare clinical and serological course are discussed.

Original languageEnglish
Pages (from-to)199-202
Number of pages4
JournalLeukemia and Lymphoma
Volume36
Issue number1-2
DOIs
StatePublished - 1999

Keywords

  • Hepatitis B
  • Interferon
  • Lymphoma

Fingerprint

Dive into the research topics of 'Seroconversion of hepatitis B during chemotherapy for malignant lymphoma'. Together they form a unique fingerprint.

Cite this